SPDR S&P Pharmaceuticals ETF
XPH
XPH
69 hedge funds and large institutions have $332M invested in SPDR S&P Pharmaceuticals ETF in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 72 → 69 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
69
Holding in Top 10
2
Calls
$218K
Puts
–
Top Buyers
| 1 | +$33.3M | |
| 2 | +$12.5M | |
| 3 | +$4.85M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.12M |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$2.06M |
Top Sellers
| 1 | -$5.19M | |
| 2 | -$4.99M | |
| 3 | -$4.75M | |
| 4 |
Jane Street
New York
|
-$3.96M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.87M |